Mirxes Holding Company
4 known investors
Find your way into Mirxes Holding Company
Sign up to see every warm intro you have to Mirxes Holding Company
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mirxes Holding Company team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mirxes develops RNA-based molecular diagnostics for early cancer detection, treatment selection, and multiomics research. Its offerings span cancer screening blood tests, next-generation sequencing panels, and bioinformatics services for clinical and research partners.
Investors · 4
How we know: Xeraya Capital's portfolio page · Not right? Tell us
How we know: funding news · sg.finance.yahoo.com · Not right? Tell us
How we know: sg.finance.yahoo.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries DJul 2023
Beijing Fupu, EDB Investments Pte Ltd, Mitsui & Co.
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Mirxes Holding Company do?
- Mirxes develops RNA-based molecular diagnostics for early cancer detection, treatment selection, and multiomics research. Its offerings span cancer screening blood tests, next-generation sequencing panels, and bioinformatics services for clinical and research partners.
- Who are Mirxes Holding Company's investors?
- Mirxes Holding Company's investors include Xeraya Capital, EDB Investments, Mitsui & Co.